Studies & Science

Live Expert Panel Discussion on the Potential Use of Adipose-derived cSVF in Treatment of Post-COVID-19 Lung Damage

SDARTs is hosting a complementary live Zoom panel discussion on the Potential Use of Adipose-derived cSVF in Treatment of Post-COVID-19 Lung Damage. SDARTs faculty members Dr. Robert W. Alexander and Dr....

Spotlight Study

Subcutaneous Injections of Nanofat Adipose-derived Stem Cell Grafting in Facial Rejuvenation

Author and SDARTs Faculty Member Sophie Menkes, MD, et al, conducted a study on the use of subcutaneous nanofat injections for facial rejuvenation. The results open up a new realm...

Spotlight Study

Nanofat Cell Aggregates: A Near Constitutive Stromal Cell Inoculum For Regenerative Site-Specific Therapies

Authors Borja Sesé (Ph.D.), SDARTs Faculty member, Ramon Llull (M.D., Ph.D.), et al, conducted a study on the cell yields of mechanically disaggregated fat tissue (Tulip True NanoFat) vs. enzymatic...

Overview of COVID-19 Lung Damage Clinical Trial Using Cellular Stromal Vascular Fraction (cSVF) and Functional Respiratory Imaging (FRI) Analysis of Pulmonary Injury & Post-Viral (SARS- CoV-2) Adult Respiratory Distress Syndrome (ARDS)

SDARTs faculty member, Robert W. Alexander, MD, DDS, is the Principle Investigator on a first-in-human clinical trial to treat post-COVID 19 survivors with AD cSVF.

Safety Guidlines for Non-Surgical Facial Procedures During COVID-19 Outbreak

Dr. Dario Bertossi, MD, et al, published safety guidelines for non-surgical facial procedures during the COVID-19 pandemic.

Potential Use of Cellular Stromal Vascular Fraction in Post-COVID-19 Pulmonary Injury and Adult Respiratory Distress Syndrome

SDARTs faculty member, Robert W. Alexander, MD, DDS, is the Principle Investigator on a first-in-human clinical trial to treat post-COVID 19 survivors with AD cSVF.